The integrated multi-omics, single-cell, spatial transcriptomic, and in vitro functional data collectively reveal that GPAA1 acts as a pro-tumorigenic factor in CRC, offering novel insights into its role in tumor progression and immunosuppression, as well as potential clinical value. Here, GPAA1 is linked to colorectal carcinoma.